2m 2m 2m 2m 2m 2m 2m
SPRUCE BIOSCIEN (SPRB)
NASDAQ
$49.90+$0.85 (+1.73%)
Price as of Jun 03, 2026 5:35 PM EDT- $141.1MMarket Cap
- 736.30%1-Year Change
- BiotechnologyIndustry
SPRUCE BIOSCIEN (SPRB)
$49.90+$0.85 (+1.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 4.9M -51.32% | 10.1M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 4.9M -51.32% | 10.1M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -19.5M N/A | N/A N/A | -49.4M +40.44% | -35.2M +14.66% | |
Depreciation and Amortization Expense | 21,000 -54.35% | 46,000 -34.29% | 70,000 -5.41% | 74,000 +8.82% | |
Total Operating Expenses | 36.5M -40.20% | 61.1M -1.64% | 62.1M +31.30% | 47.3M +12.40% | |
Operating Profit | -36.5M -34.97% | -56.2M +8.00% | -52.0M +9.96% | -47.3M +12.40% | |
Interest Income | 1.1M -66.77% | 3.4M -24.91% | 4.6M +199.21% | 1.5M N/A | |
Interest Expense | -90,000 -70.68% | -307,000 -36.44% | -483,000 +15.00% | -420,000 +21.74% | |
Interest Income and Expense and Net | 1.0M -66.39% | 3.1M -23.54% | 4.1M +269.36% | 1.1M +419.71% | |
Total Nonoperating Income and Expense | 90,000 -70.68% | 307,000 -36.44% | 483,000 +15.00% | 420,000 +252.94% | |
Income before Taxes | -36.5M -34.97% | -56.2M +8.00% | -52.0M +9.96% | -47.3M +12.40% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -39.0M -26.53% | -53.0M +10.68% | -47.9M +3.77% | -46.2M +9.19% | |
Net Income from Continuing Operations Applicable to Common | -39.0M -26.53% | -53.0M +10.68% | -47.9M +3.77% | -46.2M +9.19% | |
Basic EPS and Net Income | -50.83 +3,840.31% | -1.29 +4.03% | -1.24 -36.73% | -1.96 +8.29% | |
Diluted EPS and Net Income | -50.83 +3,840.31% | -1.29 +4.03% | -1.24 -36.73% | -1.96 +8.29% | |
Basic Weighted Average Shares | 766,598 -98.14% | 41.3M +7.15% | 38.5M +63.68% | 23.5M +0.71% | |
Diluted Weighted Average Shares | 766,598 -98.14% | 41.3M +7.15% | 38.5M +63.68% | 23.5M +0.71% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 48.9M +26.20% | 38.8M -59.77% | 96.3M +293.43% | 24.5M -42.72% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 54.6M +18.11% | |
Cash and Cash Equivalents and Short-Term Investments | 48.9M +26.20% | 38.8M -59.77% | 96.3M +21.83% | 79.1M -11.12% | |
Total Current Assets | 52.1M +17.88% | 44.2M -56.74% | 102.2M +22.22% | 83.6M -9.02% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 243,000 +252.17% | 69,000 -88.14% | 582,000 -9.06% | 640,000 +46.45% | |
Total Assets | 53.0M +17.28% | 45.2M -56.51% | 103.9M +21.36% | 85.6M -32.29% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 1.6M 0.00% | 1.6M 0.00% | 1.6M -36.49% | |
Total Current Liabilities | 10.1M -33.84% | 15.2M -37.68% | 24.5M +96.55% | 12.4M +40.31% | |
Total Long-Term Debt | 0 -100.00% | 124,000 -92.78% | 1.7M -47.86% | 3.3M -32.49% | |
Total Long-Term Liabilities | 0 -100.00% | 282,000 +19.49% | 236,000 +46.58% | 161,000 +120.55% | |
Total Liabilities | 10.5M -35.90% | 16.4M -40.27% | 27.4M +59.87% | 17.2M +13.54% | |
Retained Earnings | -289.2M +15.57% | -250.3M +26.89% | -197.2M +32.09% | -149.3M +44.78% | |
Total Stockholders Equity | 42.5M +47.52% | 28.8M -62.33% | 76.5M +11.71% | 68.5M -38.51% | |
Total Shares Outstanding | 1.4M -96.75% | 42.2M +2.93% | 41.0M +73.85% | 23.6M +0.46% | |
Cash Flow | |||||
Cash from Operating Activities | -33.3M -40.45% | -56.0M +68.19% | -33.3M -20.17% | -41.7M +16.18% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 7,000 -12.50% | 8,000 -91.40% | |
Cash from Investing Activities | N/A N/A | 0 -100.00% | 55.8M +135.43% | 23.7M +129.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 43.5M +2,780.70% | -1.6M -103.30% | 49.1M +20,490.04% | -241,000 -137.48% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -1,143.37% +121.87% | -515.34% N/A | N/A N/A | |
Return on Assets | -79.34% +11.56% | -71.12% +40.69% | -50.55% +16.10% | -43.54% +48.95% | |
Return on Equity | -109.24% +8.48% | -100.70% +52.36% | -66.10% +28.71% | -51.35% +58.33% | |
Revenue Growth | -100.00% +94.84% | -51.32% N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.17 +78.20% | 2.90 -30.58% | 4.18 -37.82% | 6.72 -35.16% | |
Cash Ratio | 4.85 +90.77% | 2.54 -35.45% | 3.94 +100.16% | 1.97 -59.17% | |
Debt-to-Equity Ratio | 0.00 -100.00% | 0.06 +38.99% | 0.04 -39.28% | 0.07 +7.65% | |
Debt-to-Assets Ratio | 0.00 -100.00% | 0.04 +20.25% | 0.03 -44.08% | 0.06 -2.38% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow